Medroxyprogesterone in the management of primary and recurrent or metastatic uterine adenocarcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D014594:Uterine Neoplasms / Q000188:drug therapy*
D008525:Medroxyprogesterone